GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
γ-amino butyric acid type A (GABAA) receptors play an important role in mediating fast synaptic inhibition in the brain. They are ubiquitously expressed in the CNS and also represent a major site of action for clinically relevant drugs. Recent technological advances have greatly clarified the molecular and cellular roles played by distinct GABAA receptor subunit classes and isoforms in normal brain function. At the same time, postmortem and genetic studies have linked neuropsychiatric disorders including schizophrenia and bipolar disorder with GABAergic neurotransmission and various specific GABAA receptor subunits, while evidence implicating GABAAR-associated proteins is beginning to emerge. In this review we discuss the mounting genetic, molecular, and cellular evidence pointing toward a role for GABAA receptor heterogeneity in both schizophrenia etiology and therapeutic development. Finally, we speculate on the relationship between schizophrenia-related disorders and selected GABAA receptor associated proteins, key regulators of GABAA receptor trafficking, targeting, clustering, and anchoring that often carry out these functions in a subtype-specific manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 8×
“Although the functional implications of the occurrence of the GEPHN gene within a schizophrenia-associated ROH have not been investigated, it is tempting to speculate on the relationship between gephyrin-mediated synaptic accumulation of α2/γ2containing GABAARs, the importance of α2/γ2-containing GABAARs concentrated…”
BackgroundInfluentialSteroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 2×
“…IH -PA Author M anuscript In addition to benzodiazepines, GABAARs are also sites for endogenous neuroactive steroids such as allopregnanolone, which potentiate the response to GABA with greater potency than benzodiazepine binding (Majewska et al., 1986; Morrow et al., 1990; Morrow et al., 1987).”
BackgroundLichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The hippocampal-VTA loop: controlling the entry of information into long-term memory
Lisman, J. E., & Grace, A. A. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.002 · Cited by 1,983
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244 · cited 4×
“This is consistent with studies showing that the GABAAR α5 subunit is highly enriched in the hippocampus over other brain regions (Fritschy and Mohler, 1995) and that α5 null mutant mice exhibit enhanced cognition (Collinson et al., 2002).”
BackgroundResultInfluentialWhich GABAA-receptor subtypes really occur in the brain?
McKernan, R. M., & Whiting, P. J. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)80023-3 · Cited by 1,222
Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P. A., Kavvoura, F. K., Khoury, M. J., Tanzi, R. E., & Bertram, L. (2008) · Nature Genetics · doi:10.1038/ng.171 · Cited by 1,054
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034 · cited 1×
“This concept has been reviewed extensively (Grace et al., 2007).”
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · cited 5×
“PV is a Ca2+-binding protein that is thought to reduce residual Ca2+ levels in axon terminals during repetitive firing, but is also postulated to prolong neurotransmitter release by maintaining elevated Ca2+ levels (Collin et al., 2005;Lisman et al., 2008).”
BackgroundMethodInfluentialAkbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882 · cited 1×
“2) (Akbarian et al., 1995;Guidotti et al., 2000;Hashimoto et al., 2008a;Hashimoto et al., 2008b;Hashimoto et al., 2005;Mirnics et al., 2000;Straub et al., 2007;Vawter et al., 2002;Volk et al., 2002).”
Cognitive Impairment in Schizophrenia Is the Core of the Disorder
Elvevag, B., & Goldberg, T. E. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.10 · Cited by 835 · cited 2×
“GABAAR as a therapeutic target for schizophrenia Given that cognitive deficits are considered to be core features of schizophrenia (Elvevag and Goldberg, 2000), and given the strong evidence implicating disturbances in GABA signaling as contributing to these deficits, it is not surprising that the…”
BackgroundMeta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811 · cited 1×
“This might be consistent with recent studies highlighting the increasingly recognized overlap in genetic vulnerability between schizophrenia and bipolar disorder (Badner and Gershon, 2002; Berrettini, 2003; Cardno et al., 2002; Fallin et al., 2005; Lichtenstein et al., 2009).”
ResultGamma Oscillations Correlate with Working Memory Load in Humans
Howard, M. W. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg084 · Cited by 766 · cited 2×
“Such synchronized networks give rise to oscillatory activity in the gamma band frequency range (30-80 Hz), which has been correlated with working memory load in healthy human subjects (Howard et al., 2003;Tamas et al., 2000) but is impaired in schizophrenic patients (Cho et al.”
BackgroundGABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition
Jacob, T. C., Moss, S. J., & Jurd, R. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2370 · Cited by 695
Self-citationEdenberg, H. J., Dick, D. M., Xuei, X., Tian, H., Almasy, L., Bauer, L. O., Crowe, R. R., Goate, A., Hesselbrock, V., Jones, K., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/383283 · Cited by 655
Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons
Tamás, G., Buhl, E. H., Lörincz, A., & Somogyi, P. (2000) · Nature Neuroscience · doi:10.1038/73936 · Cited by 648
Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Otu, F. M., Howell, O., Atack, J. R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05572.2002 · Cited by 628 · cited 1×
“This is consistent with studies showing that the GABAAR α5 subunit is highly enriched in the hippocampus over other brain regions (Fritschy and Mohler, 1995) and that α5 null mutant mice exhibit enhanced cognition (Collinson et al., 2002).”
ResultMcBain, C. J., & Fisahn, A. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049047 · Cited by 581 · cited 2×
“, 1982;Somogyi, 1977) and can thus synchronize the activity of local pyramidal cell populations (McBain and Fisahn, 2001).”
BackgroundA specific ‘axo-axonal’ interneuron in the visual cortex of the rat
Somogyi, P. (1977) · Brain Research · doi:10.1016/0006-8993(77)90808-3 · Cited by 530 · cited 1×
“2) (Conde et al., 1994;Lewis and Lund, 1990;Peters et al., 1982;Somogyi, 1977) and can thus synchronize the activity of local pyramidal cell populations (McBain and Fisahn, 2001).”
BackgroundHashimoto, T., Arion, D., Unger, T., Maldonado-Avilés, J. G., Morris, H. M., Volk, D. W., Mirnics, K., & Lewis, D. A. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002011 · Cited by 490 · cited 6×
“2) (Hashimoto et al., 2008a).”
BackgroundInfluentialLodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488
Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703806104 · Cited by 483 · cited 12×
“, 2005), which itself is thought to result from altered methylation of GAD1, the gene encoding GAD67 (Benes et al., 2007;Costa et al., 2003;Huang and Akbarian, 2007;Ruzicka et al., 2007;Tochigi et al., 2008;Veldic et al., 2007).”
BackgroundInfluentialA Twin Study of Genetic Relationships Between Psychotic Symptoms
Cardno, A. G., Rijsdijk, F. V., Sham, P. C., Murray, R. M., & McGuffin, P. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.539 · Cited by 460 · cited 1×
“This might be consistent with recent studies highlighting the increasingly recognized overlap in genetic vulnerability between schizophrenia and bipolar disorder (Badner and Gershon, 2002; Berrettini, 2003; Cardno et al., 2002; Fallin et al., 2005; Lichtenstein et al., 2009).”
ResultHashimoto, T., Bazmi, H. H., Mirnics, K., Wu, Q., Sampson, A. R., & Lewis, D. A. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07081223 · Cited by 457
Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it
Flood, J. F., Morley, J. E., & Roberts, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1567 · Cited by 436 · cited 1×
“…and its derivative pregnenolone sulfate have been shown to enhance learning and memory in rodents (Akwa et al., 2001; Darnaudery et al., 2002; Flood et al., 1992, 1995; Ladurelle et al., 2000; Mayo et al., 1993; Meziane et al., 1996; Pallares et al., 1998; Vallee et al., 1997; Vallee et al.,…”
BackgroundCamargo, L. M., Collura, V, Rain, J.-C., Mizuguchi, K., Hermjakob, H., Kerrien, S., Bonnert, T. P., Whiting, P. J., & Brandon, N. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001880 · Cited by 405 · cited 8×
“To date, DISC1 has not been associated with inhibitory synapses but it may be worth examining such a link in the future.”
BackgroundInfluentialSelf-citationMerali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., & Anisman, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4734-03.2004 · Cited by 400
A role for inhibition in shaping the temporal flow of information in prefrontal cortex
Constantinidis, C., Williams, G. V., & Goldman-Rakic, P. S. (2002) · Nature Neuroscience · doi:10.1038/nn799 · Cited by 348 · cited 1×
“Thus, in the DLPFC, GABAergic inhibition controls the timing of principal neuron activities and, in doing so, controls the temporal flow of information during working memory tasks (Constantinidis et al., 2002).”
BackgroundVawter, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00377-2 · Cited by 275
Allelic and haplotypic association of GABRA2 with alcohol dependence
Covault, J., Gelernter, J., Hesselbrock, V., Nellissery, M., & Kranzler, H. R. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30091 · Cited by 273 · cited 2×
“It might also be argued that these changes in α2 subunit expression are related to comorbid substance abuse since 1) numerous reports have demonstrated that genetic variation in the gene encoding the α2 subunit is strongly associated with risk for alcoholism (Covault et al., 2004; Covault et al., 2008; Dick et al., 20…”
BackgroundSubstance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden
Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00114-6 · Cited by 261 · cited 2×
“, 2006), and 2) substance abuse, including that of alcohol and cannabis, is the most common psychiatric comorbidity among patients with schizophrenia (Cantor-Graae et al., 2001; Mueser et al., 1990).”
BackgroundLewis, D., Volk, D., & Hashimoto, T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1673-x · Cited by 253 · cited 4×
“A similar approach in targeting specific GABAAR subtypes for improving working memory in schizophrenia has exploited the restricted localization of α2 subunit-containing GABAARs to the pyramidal neuron AIS, combined with the putative role chandelier neuron inhibition plays in generating pyramidal cell network oscillat…”
BackgroundInfluentialDisorder-associated mutations lead to functional inactivation of neuroligins
Chih, B., Afridi, S. K., Clark, L., & Scheiffele, P. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh158 · Cited by 242
An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition
Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092320 · Cited by 241
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227 · cited 1×
“Interestingly, a recent postmortem study concluded that protein and mRNA expression of septin 11, in addition to other septin family members, is significantly elevated in the DLPFC of both schizophrenic and bipolar cases compared to controls (Pennington et al., 2008).”
ResultDick, D. M., Bierut, L., Hinrichs, A., Fox, L., Bucholz, K. K., Kramer, J., Kuperman, S., Hesselbrock, V., Schuckit, M., Almasy, L., et al. (2006) · Behavior Genetics · doi:10.1007/s10519-005-9041-8 · Cited by 227 · cited 2×
“It might also be argued that these changes in α2 subunit expression are related to comorbid substance abuse since 1) numerous reports have demonstrated that genetic variation in the gene encoding the α2 subunit is strongly associated with risk for alcoholism (Covault et al., 2004; Covault et al., 2008; Dick et al., 20…”
BackgroundMayo, W., Dellu, F., Robel, P., Cherkaoui, J., Le Moal, M., Baulieu, E.-E., & Simon, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)91524-v · Cited by 212 · cited 2×
“…been shown to enhance learning and memory in rodents (Akwa et al., 2001; Darnaudery et al., 2002; Flood et al., 1992, 1995; Ladurelle et al., 2000; Mayo et al., 1993; Meziane et al., 1996; Pallares et al., 1998; Vallee et al., 1997; Vallee et al., 2001), likely due in part to the ability of…”
BackgroundYee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
Agrawal, A., Edenberg, H. J., Foroud, T., Bierut, L. J., Dunne, G., Hinrichs, A. L., Nurnberger, J. I., Crowe, R., Kuperman, S., Schuckit, M. A., et al. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9069-4 · Cited by 189
Atack, J. R., Wafford, K. A., Tye, S. J., Cook, S. M., Sohal, B., Pike, A., Sur, C., Melillo, D., Bristow, L., Bromidge, F., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089920 · Cited by 188
Developmental Changes in Parvalbumin Regulate Presynaptic Ca2+Signaling
Collin, T., Chat, M., Lucas, M. G., Moreno, H., Racay, P., Schwaller, B., Marty, A., & Llano, I. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3748-04.2005 · Cited by 183
Mhatre, M. C., Pena, G., Sieghart, W., & Ticku, M. K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09795.x · Cited by 174 · cited 1×
“…studies have demonstrated that GABAAR α2 subunit mRNA is decreased rather than increased when rats were subjected to prolonged ethanol exposure (Mhatre et al., 1993; Montpied et al., 1991), while human postmortem studies found that GABAAR α2 subunit mRNA levels were unchanged in the cerebral…”
BackgroundFlood, J. F., Morley, J. E., & Roberts, E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10806 · Cited by 171
Menzies, L., Ooi, C., Kamath, S., Suckling, J., McKenna, P., Fletcher, P., Bullmore, E., & Stephenson, C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.156 · Cited by 120
Brandon, N. J., Jovanovic, J. N., Smart, T. G., & Moss, S. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06353.2002 · Cited by 106 · cited 10×
“Consistent with this hypothesis, it has also been shown that the association of RACK1 and PKC is increased in the frontal cortex of postmortem brains of subjects with bipolar affective disorder (Wang and Friedman, 2001), which may explain the increase in PKC activity in these subjects and lends further support to the…”
BackgroundSelf-citationDrgon, T., D'Addario, C., & Uhl, G. R. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30349 · Cited by 82 · cited 2×
“, 2008) and drug abuse (Agrawal et al., 2006; Drgon et al., 2006), and 2) substance abuse, including that of alcohol and cannabis, is the most common psychiatric comorbidity among patients with schizophrenia (Cantor-Graae et al.”
Backgroundγ-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins
Alessi, A., Bragg, A. D., Percival, J. M., Yoo, J., Albrecht, D. E., Froehner, S. C., & Adams, M. E. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.019 · Cited by 60 · cited 1×
“…(ROH) associated with schizophrenia was found to occur directly in the coding region of SNTG1 (Lencz et al., 2007), a gene encoding γ-syntrophin, a brain-enriched PDZ domain-containing scaffolding protein that binds to dystrophin and is part of the dystrophin protein complex (Alessi et al., 2006).”
Background
Cited by
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
GABAA Receptor Trafficking-Mediated Plasticity of Inhibitory Synapses
Luscher, B., Fuchs, T., & Kilpatrick, C. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.024 · Cited by 434
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Hyde, T. M., Lipska, B. K., Ali, T., Mathew, S. V., Law, A. J., Metitiri, O. E., Straub, R. E., Ye, T., Colantuoni, C., Herman, M. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1234-11.2011 · Cited by 324
Drug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127
Metadata
- Authors
- Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 57
- Issue
- 5-6
- Pages
- 481-495
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2080749670
- Cited by
- 125
- References
- 51
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.